Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Genetic Testing [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
autism [NCBI] 0.00257473
RA [NCBI] 0.0023591
apnea, obstructive sleep [NCBI] 0.00188812
SLE [NCBI] 0.00164523
systemic lupus erythematosus, susceptibility to, 8 [NCBI] 0.00162105
CF [NCBI] 0.00135717
APC [NCBI] 0.00128305
systemic lupus erythematosus, susceptibility to, 7 [NCBI] 0.00125849
SRS [NCBI] 0.00120859
CELIAC2 [NCBI] 0.000985556
MAFD6 [NCBI] 0.00095754
systemic lupus erythematosus, susceptibility to, 6 [NCBI] 0.000901457
cluster headache, familial [NCBI] 0.000833662
FMTLE [NCBI] 0.000809662
wegener granulomatosis [NCBI] 0.000809662
BMND6 [NCBI] 0.000809662
SPG32 [NCBI] 0.000809662
MRXS11 [NCBI] 0.000809662
MAFD5 [NCBI] 0.000809662
MMVP2 [NCBI] 0.000809662
SPG24 [NCBI] 0.000809662
DYTCA [NCBI] 0.000809662
migraine with aura, susceptibility to, 9 [NCBI] 0.000809662
major depressive disorder 1 [NCBI] 0.000809662
polyposis, gastric [NCBI] 0.000809662
diamond-blackfan anemia 2 [NCBI] 0.000809662
ETL4 [NCBI] 0.000809662
OTSC3 [NCBI] 0.000809662
GINGF3 [NCBI] 0.000809662
AUTS6 [NCBI] 0.000648112
PDB4 [NCBI] 0.000547231
EA3 [NCBI] 0.000547231
BMND2 [NCBI] 0.000547231
HRPT3 [NCBI] 0.000547231
SCA20 [NCBI] 0.000547231
RCM2 [NCBI] 0.000547231
prostate cancer aggressiveness quantitative trait locus on chromosome 19 [NCBI] 0.000547231
DYX8 [NCBI] 0.000547231
AUTS8 [NCBI] 0.000547231
BMND5 [NCBI] 0.000547231
spondyloepiphyseal dysplasia tarda, autosomal recessive [NCBI] 0.000547231
TSD [NCBI] 0.000523564
HD [NCBI] 0.000474379
cataract, central saccular, with sutural opacities [NCBI] 0.000449913
migraine with or without aura, susceptibility to, 3 [NCBI] 0.000449913
OPA2 [NCBI] 0.000449913
cataract, autosomal recessive, early-onset, pulverulent [NCBI] 0.000449913
migraine without aura, susceptibility to, 4 [NCBI] 0.000449913
vitreoretinal degeneration, snowflake type [NCBI] 0.000449913
tune deafness [NCBI] 0.000449913
stature quantitative trait locus 2 [NCBI] 0.000449913
IBD9 [NCBI] 0.000449913
aneurysm, intracranial berry, 1 [NCBI] 0.000444888
MAFD1 [NCBI] 0.00040389
HMPS1 [NCBI] 0.000387692
EA4 [NCBI] 0.000387692
asperger syndrome, susceptibility to, 1 [NCBI] 0.000387692
PARK11 [NCBI] 0.000387692
CTAA2 [NCBI] 0.000387692
parkinson disease 12 [NCBI] 0.000387692
LGMD1D [NCBI] 0.000387692
eosinophilia, familial [NCBI] 0.000387692
lynch syndrome i [NCBI] 0.000365464
CTPP1 [NCBI] 0.00034214
electroencephalogram, low-voltage [NCBI] 0.00034214
CTAA1 [NCBI] 0.00034214
ETM2 [NCBI] 0.00034214
spondyloepiphyseal dysplasia tarda, autosomal dominant [NCBI] 0.00034214
AUTS5 [NCBI] 0.00034214
AD14 [NCBI] 0.00034214
AD13 [NCBI] 0.00034214
restless legs syndrome, susceptibility to, 1 [NCBI] 0.000338475
MODY [NCBI] 0.000316908
SCAX1 [NCBI] 0.000306405
CCA1 [NCBI] 0.000306405
CHED1 [NCBI] 0.000306405
hereditary motor and sensory neuropathy v [NCBI] 0.000306405
NIDDM2 [NCBI] 0.000306405
holoprosencephaly [NCBI] 0.000303402
progeroid syndrome, neonatal [NCBI] 0.000277159
neuropathy, hereditary motor and sensory, russe type [NCBI] 0.000277159
MEAX [NCBI] 0.000277159
MSSE [NCBI] 0.000277159
BMND3 [NCBI] 0.000277159
MYMY1 [NCBI] 0.000277159
APOE [NCBI] 0.000264724
prostate cancer, hereditary, 8 [NCBI] 0.000252523
CFTR [NCBI] 0.000240189
EGF [NCBI] 0.00023821
IBD2 [NCBI] 0.000231334
spinocerebellar ataxia 29 [NCBI] 0.000231334
RTT [NCBI] 0.000220333
HPCX [NCBI] 0.000212822
GJB2 [NCBI] 0.00020085
CRC [NCBI] 0.000200155
BRCA1 [NCBI] 0.000196546
OTSC1 [NCBI] 0.000196448
SMA3 [NCBI] 0.000182469
anencephaly [NCBI] 0.000181822
MG [NCBI] 0.000176793
SMA2 [NCBI] 0.000166536
MDD [NCBI] 0.000163638
GCE [NCBI] 0.000155405
DURS1 [NCBI] 0.000145824
alopecia areata 1 [NCBI] 0.000145824
LDLR [NCBI] 0.000145328
LRRK2 [NCBI] 0.000141858
NGFB [NCBI] 0.000139455
lymphoma, non-hodgkin, familial [NCBI] 0.000138769
VEGF [NCBI] 0.000135108
SMN2 [NCBI] 0.000132077
SMN1 [NCBI] 0.000128925
autism, x-linked, susceptibility to, 1 [NCBI] 0.000127937
NS4 [NCBI] 0.000127937
TNF [NCBI] 0.000126565
SMEI [NCBI] 0.000124095
PRL [NCBI] 0.000121619
biotinidase deficiency [NCBI] 0.000121588
MS [NCBI] 0.00012096
SHFM3 [NCBI] 0.000118211
IGAN1 [NCBI] 0.000118211
spermatogenic failure, nonobstructive, y-linked [NCBI] 0.000115212
PTH [NCBI] 0.000112954
asthma, susceptibility to [NCBI] 0.000111116
ALS1 [NCBI] 0.000111116
trigonocephaly, nonsyndromic [NCBI] 0.000110968
BRCA2 [NCBI] 0.000106718
VUR1 [NCBI] 0.000103088
JBTS1 [NCBI] 0.000103088
chiari malformation type i [NCBI] 0.000103088
SMA1 [NCBI] 0.000101057
MECP2 [NCBI] 0.000100378
CTPP3 [NCBI] 9.9419e-05
3-@methylglutaconic aciduria, type iii [NCBI] 9.9419e-05
renal tubular acidosis, distal, with hemolytic anemia [NCBI] 9.9419e-05
PARK6 [NCBI] 9.83174e-05
LGMD2A [NCBI] 9.69385e-05
FMF [NCBI] 9.51754e-05
ABCC6 [NCBI] 9.18643e-05
phenylketonuria [NCBI] 9.12118e-05
PXE [NCBI] 9.0941e-05
PARK8 [NCBI] 8.4918e-05
ENG [NCBI] 8.47367e-05
diabetes mellitus, transient neonatal, 1 [NCBI] 8.40861e-05
mycobacterium tuberculosis, susceptibility to, x-linked [NCBI] 8.29277e-05
fibuloulnar aplasia or hypoplasia with renal abnormalities [NCBI] 8.29277e-05
CORD10 [NCBI] 8.29277e-05
CISS1 [NCBI] 8.29277e-05
3-@methylglutaconic aciduria, type v [NCBI] 8.29277e-05
RESDX [NCBI] 8.29277e-05
RP35 [NCBI] 8.29277e-05
scaphocephaly, maxillary retrusion, and mental retardation [NCBI] 8.29277e-05
RYR1 [NCBI] 8.25775e-05
ACHE [NCBI] 8.23201e-05
ACADM [NCBI] 8.0833e-05
PSEN1 [NCBI] 7.96401e-05
HSAN3 [NCBI] 7.93786e-05
SANDO [NCBI] 7.76716e-05
prostate cancer/brain cancer susceptibility [NCBI] 7.76716e-05
DM2 [NCBI] 7.61076e-05
alcohol dependence [NCBI] 7.44164e-05
NPY [NCBI] 7.41362e-05
AOS [NCBI] 7.33806e-05
migraine with or without aura, susceptibility to, 1 [NCBI] 7.33806e-05
PKHD1 [NCBI] 7.31578e-05
CMT4B2 [NCBI] 7.26102e-05
SCA12 [NCBI] 7.26102e-05
SPG4 [NCBI] 7.25401e-05
ELAC2 [NCBI] 7.15349e-05
CHEK2 [NCBI] 6.9297e-05
GLDC [NCBI] 6.85995e-05
MHS1 [NCBI] 6.73257e-05
neural tube defects [NCBI] 6.58542e-05
POLG [NCBI] 6.50529e-05
MODY3 [NCBI] 6.42741e-05
BOS1 [NCBI] 6.42741e-05
CMT2A2 [NCBI] 6.42741e-05
FRNS [NCBI] 6.39564e-05
CAPN10 [NCBI] 6.25888e-05
MRXS13 [NCBI] 6.07649e-05
SACS [NCBI] 6.07649e-05
HFE [NCBI] 6.05257e-05
GCK [NCBI] 5.86489e-05
GFAP [NCBI] 5.72099e-05
EVA [NCBI] 5.5504e-05
myoclonic dystonia [NCBI] 5.5504e-05
SPG4 [NCBI] 5.5504e-05
myopathy, spheroid body [NCBI] 5.54754e-05
BOR2 [NCBI] 5.54754e-05
SCA16 [NCBI] 5.54754e-05
SCAR8 [NCBI] 5.54754e-05
MODY6 [NCBI] 5.54754e-05
CMT1D [NCBI] 5.54754e-05
HMN7B [NCBI] 5.54754e-05
CMT2K [NCBI] 5.54754e-05
prostate cancer [NCBI] 5.53637e-05
EPO [NCBI] 5.53323e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive [NCBI] 5.46983e-05
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis [NCBI] 5.46983e-05
mucolipidosis iiia [NCBI] 5.46983e-05
CAPN3 [NCBI] 5.46764e-05
MTRNR1 [NCBI] 5.46764e-05
PD [NCBI] 5.44571e-05
MYOC [NCBI] 5.40537e-05
RECQL3 [NCBI] 5.39493e-05
fragile x mental retardation syndrome [NCBI] 5.38863e-05
MEN2A [NCBI] 5.22841e-05
LGMD2B [NCBI] 5.20449e-05
ERDA1 [NCBI] 5.18256e-05
MCOLN1 [NCBI] 5.17902e-05
IKBKAP [NCBI] 5.17902e-05
G6PD [NCBI] 5.11067e-05
RB1 [NCBI] 5.07162e-05
FANCA [NCBI] 5.06378e-05
BTD [NCBI] 5.04399e-05
TPMT [NCBI] 5.00754e-05
GLC1A [NCBI] 4.98083e-05
HSAN2 [NCBI] 4.95974e-05
AD [NCBI] 4.93645e-05
CRH [NCBI] 4.84602e-05
ABCA4 [NCBI] 4.77661e-05
FXTAS [NCBI] 4.73293e-05
HPC1 [NCBI] 4.73293e-05
infantile spasm syndrome, x-linked [NCBI] 4.73293e-05
alkaptonuria [NCBI] 4.73293e-05
SQSTM1 [NCBI] 4.59111e-05
IBD1 [NCBI] 4.58235e-05
EGFR [NCBI] 4.5601e-05
ALPS2A [NCBI] 4.5314e-05
spondyloepiphyseal dysplasia, kimberley type [NCBI] 4.5314e-05
parathyroid carcinoma [NCBI] 4.5314e-05
mass syndrome [NCBI] 4.5314e-05
otofaciocervical syndrome [NCBI] 4.5314e-05
charcot-marie-tooth disease, axonal, type 2f [NCBI] 4.5314e-05
MRX63 [NCBI] 4.5314e-05
PEE4 [NCBI] 4.5314e-05
siderius x-linked mental retardation syndrome [NCBI] 4.5314e-05
HMERF [NCBI] 4.5314e-05
MODY4 [NCBI] 4.5314e-05
JPHT [NCBI] 4.5314e-05
diabetic nephropathy, susceptibility to [NCBI] 4.5314e-05
hydrocephalus due to congenital stenosis of aqueduct of sylvius [NCBI] 4.5314e-05
FTLDU [NCBI] 4.52186e-05
MBP [NCBI] 4.52016e-05
AT [NCBI] 4.5041e-05
SGCE [NCBI] 4.49465e-05
FRAXE [NCBI] 4.49465e-05
HEXA [NCBI] 4.46321e-05
HNF1A [NCBI] 4.40406e-05
HMBS [NCBI] 4.34679e-05
homocystinuria [NCBI] 4.3463e-05
EBN1 [NCBI] 4.32473e-05
brugada syndrome 1 [NCBI] 4.32473e-05
bethlem myopathy [NCBI] 4.32473e-05
MFS [NCBI] 4.20257e-05
MSH2 [NCBI] 4.17282e-05
SCA10 [NCBI] 4.14002e-05
HEPOD [NCBI] 4.14002e-05
ORW2 [NCBI] 4.14002e-05
PSEN2 [NCBI] 4.09367e-05
PINK1 [NCBI] 4.08167e-05
GABRA4 [NCBI] 4.05535e-05
SCA17 [NCBI] 3.96646e-05
PRTS [NCBI] 3.8828e-05
charcot-marie-tooth disease, recessive intermediate a [NCBI] 3.8828e-05
SPG8 [NCBI] 3.8828e-05
SPD2 [NCBI] 3.8828e-05
weyers ulnar ray/oligodactyly syndrome [NCBI] 3.8828e-05
SCA13 [NCBI] 3.8828e-05
isobutyryl-coa dehydrogenase deficiency [NCBI] 3.8828e-05
EBN2 [NCBI] 3.8828e-05
PRD [NCBI] 3.8828e-05
HPA1 [NCBI] 3.8828e-05
varicose veins [NCBI] 3.8828e-05
CMT4H [NCBI] 3.8828e-05
spongiform encephalopathy with neuropsychiatric features [NCBI] 3.8828e-05
AIS1 [NCBI] 3.8828e-05
rett syndrome, atypical, cdkl5-related [NCBI] 3.8828e-05
LGMD2K [NCBI] 3.8828e-05
CORDX3 [NCBI] 3.8828e-05
CMT1C [NCBI] 3.8828e-05
orofacial cleft 5 [NCBI] 3.8828e-05
SPG7 [NCBI] 3.8828e-05
LS [NCBI] 3.87504e-05
NHLRC1 [NCBI] 3.83889e-05
KCNQ3 [NCBI] 3.83889e-05
ARX [NCBI] 3.75172e-05
NF2 [NCBI] 3.75035e-05
MPO [NCBI] 3.71845e-05
PKD1 [NCBI] 3.6781e-05
FTL [NCBI] 3.58179e-05
MC4R [NCBI] 3.58175e-05
MAOB [NCBI] 3.52892e-05
RMD [NCBI] 3.50249e-05
acyl-coa dehydrogenase, medium-chain, deficiency of [NCBI] 3.50249e-05
andersen cardiodysrhythmic periodic paralysis [NCBI] 3.50249e-05
SACS [NCBI] 3.50004e-05
MLH1 [NCBI] 3.46484e-05
RET [NCBI] 3.45266e-05
CCZS [NCBI] 3.40875e-05
NEM1 [NCBI] 3.40875e-05
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance [NCBI] 3.40875e-05
NAIC [NCBI] 3.40875e-05
KRS [NCBI] 3.40875e-05
LVNC1 [NCBI] 3.40875e-05
CMD1D [NCBI] 3.40875e-05
VF [NCBI] 3.40875e-05
epidermolysis bullosa herpetiformis, dowling-meara type [NCBI] 3.40875e-05
PDB1 [NCBI] 3.40875e-05
MTM1 [NCBI] 3.39279e-05
FSHMD1A [NCBI] 3.36514e-05
PNKD1 [NCBI] 3.36401e-05
SOS1 [NCBI] 3.36219e-05
CVID [NCBI] 3.35265e-05
NPPA [NCBI] 3.31322e-05
RHO [NCBI] 3.30181e-05
SLC26A4 [NCBI] 3.2881e-05
CHAT [NCBI] 3.27107e-05
NEUROD1 [NCBI] 3.2393e-05
STK11 [NCBI] 3.15952e-05
ATP7B [NCBI] 3.15952e-05
GRN [NCBI] 3.15952e-05
pygopus, drosophila, homolog of, 1 [NCBI] 3.15759e-05
P2RY8 [NCBI] 3.15759e-05
GNL2 [NCBI] 3.15759e-05
KLHL4 [NCBI] 3.15759e-05
kiaa2022 [NCBI] 3.15759e-05
pygopus, drosophila, homolog of, 2 [NCBI] 3.15759e-05
DFNB1 [NCBI] 3.10741e-05
mucopolysaccharidosis type iva [NCBI] 3.07935e-05
PCOS1 [NCBI] 3.06731e-05
HEXB [NCBI] 3.04077e-05
choreoathetosis, hypothyroidism, and neonatal respiratory distress [NCBI] 3.03752e-05
MRXSL [NCBI] 3.03752e-05
HDL1 [NCBI] 3.03752e-05
HOA [NCBI] 3.03752e-05
stickler syndrome, type i, nonsyndromic ocular [NCBI] 3.03752e-05
cataract, lamellar [NCBI] 3.03752e-05
corneal dystrophy, epithelial basement membrane [NCBI] 3.03752e-05
basal ganglia disease, adult-onset [NCBI] 3.03752e-05
azoospermia due to perturbations of meiosis [NCBI] 3.03752e-05
minicore myopathy with external ophthalmoplegia [NCBI] 3.03752e-05
SPDA1 [NCBI] 2.98827e-05
myoclonic epilepsy of lafora [NCBI] 2.98827e-05
TPH2 [NCBI] 2.93516e-05
HCRTR2 [NCBI] 2.93516e-05
HGD [NCBI] 2.93516e-05
alzheimer disease 3 [NCBI] 2.87464e-05
mycobacterium tuberculosis, susceptibility to [NCBI] 2.87464e-05
hemophilia a [NCBI] 2.8e-05
CACNA1A [NCBI] 2.79501e-05
apc gene [NCBI] 2.78565e-05
NIDDM [NCBI] 2.78181e-05
TNFRSF11A [NCBI] 2.7705e-05
GDAP1 [NCBI] 2.7705e-05
STL1 [NCBI] 2.76613e-05
RP3 [NCBI] 2.76613e-05
CCA2 [NCBI] 2.73421e-05
CLN6 [NCBI] 2.73421e-05
PC1 [NCBI] 2.73421e-05
CCM3 [NCBI] 2.73421e-05
amme complex [NCBI] 2.73421e-05
IDDM5 [NCBI] 2.73421e-05
short stature, idiopathic, autosomal [NCBI] 2.73421e-05
HGPPS [NCBI] 2.73421e-05
CZP3 [NCBI] 2.73421e-05
FHL2 [NCBI] 2.73421e-05
FBN1 [NCBI] 2.62981e-05
USH2A [NCBI] 2.62728e-05
SLC16A2 [NCBI] 2.62728e-05
VHL [NCBI] 2.61667e-05
periodic fever, familial, autosomal dominant [NCBI] 2.56311e-05
gastric cancer [NCBI] 2.56311e-05
RPGR [NCBI] 2.55607e-05
HBD [NCBI] 2.52877e-05
CDH1 [NCBI] 2.50196e-05
TNFRSF13B [NCBI] 2.5007e-05
citrullinemia, type ii, neonatal-onset [NCBI] 2.4792e-05
CHED2 [NCBI] 2.4792e-05
rheumatoid arthritis, systemic juvenile [NCBI] 2.4792e-05
PARK7 [NCBI] 2.4792e-05
VMCM [NCBI] 2.4792e-05
monosomy 1p36 syndrome [NCBI] 2.4792e-05
ODG2 [NCBI] 2.4792e-05
IBMPFD [NCBI] 2.4792e-05
creatine deficiency syndrome, x-linked [NCBI] 2.4792e-05
BPP [NCBI] 2.4792e-05
PARK4 [NCBI] 2.4792e-05
CMT4B1 [NCBI] 2.4792e-05
PKS [NCBI] 2.46801e-05
PARK2 [NCBI] 2.46801e-05
PGL1 [NCBI] 2.46801e-05
CMT1A [NCBI] 2.45744e-05
GALK1 [NCBI] 2.44256e-05
NEB [NCBI] 2.44256e-05
PMP22 [NCBI] 2.4326e-05
hypercholesterolemia, autosomal dominant [NCBI] 2.42455e-05
HAMP [NCBI] 2.38742e-05
FLT3 [NCBI] 2.38742e-05
MJD [NCBI] 2.36124e-05
GTS [NCBI] 2.34429e-05
DHFR [NCBI] 2.339e-05
hypertension, essential [NCBI] 2.33816e-05
CCDC28B [NCBI] 2.33578e-05
KRTHB3 [NCBI] 2.33578e-05
ww domain-containing protein, 45-kd [NCBI] 2.33578e-05
BPY2 [NCBI] 2.33578e-05
SRPX2 [NCBI] 2.33578e-05
DNAJC19 [NCBI] 2.33578e-05
TTTY17 [NCBI] 2.33578e-05
TTTY4 [NCBI] 2.33578e-05
tetracycline transporter-like protein [NCBI] 2.33578e-05
CSPG4LY [NCBI] 2.33578e-05
IMPG2 [NCBI] 2.33578e-05
GOLGA2LY [NCBI] 2.33578e-05
OPA3 [NCBI] 2.33578e-05
RPS6KA6 [NCBI] 2.33578e-05
TTTY3 [NCBI] 2.33578e-05
FAM14A [NCBI] 2.33578e-05
TTTY5 [NCBI] 2.33578e-05
TTTY6 [NCBI] 2.33578e-05
MTNR1B [NCBI] 2.33578e-05
MM [NCBI] 2.28932e-05
PCTT [NCBI] 2.28932e-05
GJB3 [NCBI] 2.285e-05
arbitrary restriction polymorphism 1 [NCBI] 2.26028e-05
fructose-1,6-bisphosphatase deficiency [NCBI] 2.26028e-05
immunoosseous dysplasia, schimke type [NCBI] 2.26028e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2 [NCBI] 2.26028e-05
MODY2 [NCBI] 2.26028e-05
emanuel syndrome [NCBI] 2.26028e-05
3-@methylglutaconic aciduria, type i [NCBI] 2.26028e-05
HSR [NCBI] 2.23728e-05
MFN2 [NCBI] 2.23728e-05
CLN3 [NCBI] 2.2053e-05
HBB [NCBI] 2.19456e-05
EGR2 [NCBI] 2.19163e-05
SLC3A1 [NCBI] 2.19163e-05
FTD [NCBI] 2.16299e-05
PARK2 [NCBI] 2.13029e-05
LFS1 [NCBI] 2.12455e-05
PWS [NCBI] 2.12277e-05
OPA1 [NCBI] 2.10591e-05
ATXN8OS [NCBI] 2.10591e-05
EYA1 [NCBI] 2.10591e-05
ADH2 [NCBI] 2.10591e-05
SCN3 [NCBI] 2.06938e-05
PARK1 [NCBI] 2.06938e-05
spinocerebellar ataxia, 16q22-linked [NCBI] 2.06938e-05
CMT4D [NCBI] 2.06938e-05
HCHWAD [NCBI] 2.06938e-05
CTLN2 [NCBI] 2.06938e-05
CSNB2A [NCBI] 2.06938e-05
CMT4C [NCBI] 2.06938e-05
DYT1 [NCBI] 2.06557e-05
contractural arachnodactyly, congenital [NCBI] 2.06557e-05
PDS [NCBI] 2.04689e-05
ATP13A2 [NCBI] 2.02743e-05
HS1BP3 [NCBI] 2.02743e-05
TMEM27 [NCBI] 2.02743e-05
STOX1 [NCBI] 2.02743e-05
ACAD8 [NCBI] 2.02743e-05
PLEK [NCBI] 2.02743e-05
AGTPBP1 [NCBI] 2.02743e-05
IARS [NCBI] 2.02743e-05
SMARCAL1 [NCBI] 2.02743e-05
EMILIN2 [NCBI] 2.02743e-05
RPPH1 [NCBI] 2.02743e-05
IGF2BP3 [NCBI] 2.02743e-05
BCL9 [NCBI] 2.02743e-05
ZWINT [NCBI] 2.02743e-05
PDCD10 [NCBI] 2.02743e-05
PRY2 [NCBI] 2.02743e-05
PHC1 [NCBI] 2.02743e-05
CAMTA2 [NCBI] 2.02743e-05
LBX2 [NCBI] 2.02743e-05
FBN3 [NCBI] 2.02743e-05
C1NH [NCBI] 2.02675e-05
PTEN [NCBI] 2.00148e-05
HSPB1 [NCBI] 1.98935e-05
GIST [NCBI] 1.97949e-05
ACVRL1 [NCBI] 1.95327e-05
NPC1 [NCBI] 1.95327e-05
COL6A1 [NCBI] 1.91843e-05
MEFV [NCBI] 1.91843e-05
CPI [NCBI] 1.91387e-05
galactokinase deficiency [NCBI] 1.90088e-05
HNPCC2 [NCBI] 1.90088e-05
CDL1 [NCBI] 1.90088e-05
SCA14 [NCBI] 1.90088e-05
POAG [NCBI] 1.90022e-05
DYSF [NCBI] 1.88476e-05
MTND5 [NCBI] 1.88476e-05
FGFR2 [NCBI] 1.88218e-05
BBS [NCBI] 1.88084e-05
RSTS [NCBI] 1.83091e-05
CENPI [NCBI] 1.82823e-05
DNMBP [NCBI] 1.82823e-05
PRY [NCBI] 1.82823e-05
CHGB [NCBI] 1.82823e-05
BBS2 [NCBI] 1.82823e-05
OSR2 [NCBI] 1.82823e-05
NELF [NCBI] 1.82823e-05
FBXO4 [NCBI] 1.82823e-05
FBXW2 [NCBI] 1.82823e-05
solute carrier family 26 (anion transporter), member 6: slc26a6 [NCBI] 1.82823e-05
CHRM2 [NCBI] 1.82823e-05
MYOM1 [NCBI] 1.82823e-05
BOLL [NCBI] 1.82823e-05
PJS [NCBI] 1.81671e-05
MPZ [NCBI] 1.8062e-05
MEN1 [NCBI] 1.8062e-05
SLOS [NCBI] 1.78622e-05
HAE [NCBI] 1.76411e-05
CPE [NCBI] 1.75926e-05
amyloidosis, primary cutaneous [NCBI] 1.75067e-05
encephalopathy, neonatal severe, due to mecp2 mutations [NCBI] 1.75067e-05
CMT4A [NCBI] 1.75067e-05
SMA4 [NCBI] 1.75067e-05
SEDT [NCBI] 1.75067e-05
HRPT2 [NCBI] 1.75067e-05
LIS1 [NCBI] 1.75067e-05
MTC [NCBI] 1.75067e-05
renal cysts and diabetes syndrome [NCBI] 1.75067e-05
LGMD2H [NCBI] 1.75067e-05
sertoli cell-only syndrome, y-linked [NCBI] 1.75067e-05
HPE2 [NCBI] 1.75067e-05
JAG1 [NCBI] 1.70365e-05
porphyria, acute intermittent [NCBI] 1.69969e-05
JPS [NCBI] 1.69969e-05
LMNA [NCBI] 1.68475e-05
wilson disease [NCBI] 1.68271e-05
STX12 [NCBI] 1.68086e-05
IPMK [NCBI] 1.68086e-05
NYX [NCBI] 1.68086e-05
GDF9 [NCBI] 1.68086e-05
OPTC [NCBI] 1.68086e-05
POLRMT [NCBI] 1.68086e-05
GNPTAB [NCBI] 1.68086e-05
DCDC2 [NCBI] 1.68086e-05
PHF8 [NCBI] 1.68086e-05
FOXI1 [NCBI] 1.68086e-05
COMMD1 [NCBI] 1.68086e-05
ZW10 [NCBI] 1.68086e-05
CLN6 [NCBI] 1.68086e-05
KCNC3 [NCBI] 1.68086e-05
CPA4 [NCBI] 1.68086e-05
TTDN1 [NCBI] 1.68086e-05
ALG12 [NCBI] 1.68086e-05
RABPT5 [NCBI] 1.68086e-05
MX1 [NCBI] 1.68086e-05
SOX14 [NCBI] 1.68086e-05
BCNS [NCBI] 1.66606e-05
TP53 [NCBI] 1.66529e-05
alzheimer disease 2 [NCBI] 1.61569e-05
NM [NCBI] 1.61569e-05
CDGG1 [NCBI] 1.61569e-05
USH3 [NCBI] 1.61569e-05
chromosome 22q13.3 deletion syndrome [NCBI] 1.61569e-05
LDS [NCBI] 1.61569e-05
monilethrix [NCBI] 1.61569e-05
pearson marrow-pancreas syndrome [NCBI] 1.61569e-05
synovitis, granulomatous, with uveitis and cranial neuropathies [NCBI] 1.61569e-05
PI [NCBI] 1.58288e-05
ALGS1 [NCBI] 1.57757e-05
BTNL2 [NCBI] 1.56402e-05
NLGN4 [NCBI] 1.56402e-05
HSN2 [NCBI] 1.56402e-05
MAD1L1 [NCBI] 1.56402e-05
PCDH8 [NCBI] 1.56402e-05
HAX1 [NCBI] 1.56402e-05
FBXO5 [NCBI] 1.56402e-05
SRI [NCBI] 1.56402e-05
TEGT [NCBI] 1.56402e-05
KCNN3 [NCBI] 1.56402e-05
MOCS1 [NCBI] 1.56402e-05
CDY1 [NCBI] 1.56402e-05
NFIL3 [NCBI] 1.56402e-05
MTTH [NCBI] 1.56402e-05
LSS [NCBI] 1.56402e-05
TNNT3 [NCBI] 1.56402e-05
MLH3 [NCBI] 1.56402e-05
OLIG1 [NCBI] 1.56402e-05
IMPA2 [NCBI] 1.56402e-05
NDUFS1 [NCBI] 1.56402e-05
BBS1 [NCBI] 1.56402e-05
CNTN4 [NCBI] 1.56402e-05
CAMTA1 [NCBI] 1.56402e-05
DLG5 [NCBI] 1.56402e-05
FBXL3 [NCBI] 1.56402e-05
TG [NCBI] 1.55601e-05
WAS [NCBI] 1.55286e-05
MAOA [NCBI] 1.53525e-05
DAZ [NCBI] 1.52785e-05
SCA6 [NCBI] 1.51967e-05
APOB [NCBI] 1.51007e-05
LGMD2I [NCBI] 1.4936e-05
CORDX1 [NCBI] 1.4936e-05
MODY1 [NCBI] 1.4936e-05
mitochondrial dna depletion syndrome, hepatocerebral form [NCBI] 1.4936e-05
BHD [NCBI] 1.4936e-05
ISS [NCBI] 1.4936e-05
ARVD1 [NCBI] 1.4936e-05
diabetes insipidus, nephrogenic, autosomal [NCBI] 1.4936e-05
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 1.4936e-05
WGN1 [NCBI] 1.4936e-05
tetralogy of fallot [NCBI] 1.4936e-05
langer mesomelic dysplasia [NCBI] 1.4936e-05
L1CAM [NCBI] 1.4831e-05
SYNE1 [NCBI] 1.46735e-05
NKX2-2 [NCBI] 1.46735e-05
FBXW4 [NCBI] 1.46735e-05
FGD4 [NCBI] 1.46735e-05
CHD7 [NCBI] 1.46735e-05
PPARGC1B [NCBI] 1.46735e-05
MUC3A [NCBI] 1.46735e-05
TTID [NCBI] 1.46735e-05
KCNE3 [NCBI] 1.46735e-05
HRPT2 [NCBI] 1.46735e-05
SEMA4A [NCBI] 1.46735e-05
RBMY1A1 [NCBI] 1.46735e-05
DYX1C1 [NCBI] 1.46735e-05
myofibrillogenesis regulator 1 [NCBI] 1.46735e-05
P2RY12 [NCBI] 1.46735e-05
VPS13A [NCBI] 1.46735e-05
CHMP4B [NCBI] 1.46735e-05
IL23R [NCBI] 1.46735e-05
CRYM [NCBI] 1.46735e-05
HCRT [NCBI] 1.44043e-05
CFH [NCBI] 1.43728e-05
GJB1 [NCBI] 1.4256e-05
RP2 [NCBI] 1.41981e-05
PRNP [NCBI] 1.41603e-05
MAPT [NCBI] 1.39126e-05
NIPBL [NCBI] 1.38502e-05
EPB72 [NCBI] 1.38502e-05
TRIM32 [NCBI] 1.38502e-05
LPIN2 [NCBI] 1.38502e-05
ISL1 [NCBI] 1.38502e-05
CLCN2 [NCBI] 1.38502e-05
USH3A [NCBI] 1.38502e-05
RXRG [NCBI] 1.38502e-05
TAS2R16 [NCBI] 1.38502e-05
CHIT1 [NCBI] 1.38502e-05
cocaine- and amphetamine-regulated transcript [NCBI] 1.38502e-05
FSCN2 [NCBI] 1.38502e-05
SLC25A13 [NCBI] 1.38502e-05
RAB5A [NCBI] 1.38502e-05
ADLTE [NCBI] 1.38255e-05
BHC [NCBI] 1.38255e-05
alpha-thalassemia/mental retardation syndrome, deletion-type [NCBI] 1.38255e-05
lipoid congenital adrenal hyperplasia [NCBI] 1.38255e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1 [NCBI] 1.38255e-05
JH [NCBI] 1.38255e-05
holocarboxylase synthetase deficiency [NCBI] 1.38255e-05
PPCD1 [NCBI] 1.38255e-05
CJD [NCBI] 1.37311e-05
COMT [NCBI] 1.36627e-05
APS1 [NCBI] 1.36357e-05
CDKN2A [NCBI] 1.35795e-05
HHT [NCBI] 1.35752e-05
down syndrome [NCBI] 1.35752e-05
FMR1 [NCBI] 1.35188e-05
leber optic atrophy [NCBI] 1.34836e-05
JAK2 [NCBI] 1.34408e-05
GDNF [NCBI] 1.33239e-05
HBA2 [NCBI] 1.32561e-05
GAB2 [NCBI] 1.31341e-05
GCLM [NCBI] 1.31341e-05
BDKRB2 [NCBI] 1.31341e-05
COL9A2 [NCBI] 1.31341e-05
OPHN1 [NCBI] 1.31341e-05
CRLF1 [NCBI] 1.31341e-05
SIP1 [NCBI] 1.31341e-05
CASP10 [NCBI] 1.31341e-05
BCKDHB [NCBI] 1.31341e-05
CITED2 [NCBI] 1.31341e-05
PPP2R2B [NCBI] 1.31341e-05
ABCA2 [NCBI] 1.31341e-05
hemojuvelin [NCBI] 1.31341e-05
PRG1 [NCBI] 1.31341e-05
GRHPR [NCBI] 1.31341e-05
HBQ1 [NCBI] 1.31341e-05
HCF2 [NCBI] 1.31341e-05
BSCL2 [NCBI] 1.31341e-05
WBS [NCBI] 1.30764e-05
A2M [NCBI] 1.30516e-05
DRD2 [NCBI] 1.28742e-05
NAT1 [NCBI] 1.28742e-05
IS1 [NCBI] 1.28216e-05
NBIA1 [NCBI] 1.28106e-05
pseudoxanthoma elasticum, forme fruste [NCBI] 1.28106e-05
IGF2 [NCBI] 1.27003e-05
RP1 [NCBI] 1.25012e-05
SHANK3 [NCBI] 1.25012e-05
AGC1 [NCBI] 1.25012e-05
KRTHB6 [NCBI] 1.25012e-05
SCN1B [NCBI] 1.25012e-05
HBE1 [NCBI] 1.25012e-05
ATP8B1 [NCBI] 1.25012e-05
LITAF [NCBI] 1.25012e-05
AIP [NCBI] 1.25012e-05
CDH13 [NCBI] 1.25012e-05
SREBF2 [NCBI] 1.25012e-05
CDKL5 [NCBI] 1.25012e-05
PRKG1 [NCBI] 1.25012e-05
IMPDH1 [NCBI] 1.25012e-05
SHBG [NCBI] 1.23892e-05
NOS3 [NCBI] 1.21987e-05
PKD2 [NCBI] 1.21987e-05
ARPKD [NCBI] 1.21105e-05
SLC17A5 [NCBI] 1.19349e-05
TREM2 [NCBI] 1.19349e-05
FACL4 [NCBI] 1.19349e-05
BARD1 [NCBI] 1.19349e-05
KRT16 [NCBI] 1.19349e-05
SGCG [NCBI] 1.19349e-05
TIMP2 [NCBI] 1.19349e-05
RBBP8 [NCBI] 1.19349e-05
CBFB [NCBI] 1.19349e-05
hyperlipoproteinemia, type i [NCBI] 1.18794e-05
molybdenum cofactor deficiency [NCBI] 1.18794e-05
diarrhea 1, secretory chloride, congenital [NCBI] 1.18794e-05
ICP [NCBI] 1.18794e-05
diabetes-deafness syndrome, maternally transmitted [NCBI] 1.18794e-05
EEC3 [NCBI] 1.18794e-05
thyroid hormonogenesis, genetic defect in, 2a [NCBI] 1.18794e-05
AHDS [NCBI] 1.18794e-05
neuropathy, congenital hypomyelinating [NCBI] 1.18794e-05
acromegaly [NCBI] 1.18794e-05
SPCH1 [NCBI] 1.18794e-05
ALD [NCBI] 1.16003e-05
MLC1 [NCBI] 1.14228e-05
BRIP1 [NCBI] 1.14228e-05
PITX3 [NCBI] 1.14228e-05
TGFB3 [NCBI] 1.14228e-05
FLCN [NCBI] 1.14228e-05
UBQLN1 [NCBI] 1.14228e-05
ERAF [NCBI] 1.14228e-05
SCN8A [NCBI] 1.14228e-05
SOAT1 [NCBI] 1.14228e-05
ZNF9 [NCBI] 1.14228e-05
MS4A2 [NCBI] 1.14228e-05
C10ORF2 [NCBI] 1.14228e-05
BFSP2 [NCBI] 1.14228e-05
GCCR [NCBI] 1.12766e-05
amyloidosis vi [NCBI] 1.12311e-05
CHM [NCBI] 1.12123e-05
EAOH [NCBI] 1.1022e-05
EA2 [NCBI] 1.1022e-05
FHM2 [NCBI] 1.1022e-05
MATN3 [NCBI] 1.0956e-05
NPC2 [NCBI] 1.0956e-05
SULT1A1 [NCBI] 1.0956e-05
OLIG2 [NCBI] 1.0956e-05
GNAQ [NCBI] 1.0956e-05
OCRL [NCBI] 1.0956e-05
CRYGC [NCBI] 1.0956e-05
CDC25A [NCBI] 1.0956e-05
SELL [NCBI] 1.0956e-05
SLS [NCBI] 1.07849e-05
CHS [NCBI] 1.05558e-05
GARS [NCBI] 1.05274e-05
TRAPPC2 [NCBI] 1.05274e-05
MEST [NCBI] 1.05274e-05
C5R1 [NCBI] 1.05274e-05
SFTPA1 [NCBI] 1.05274e-05
MSR1 [NCBI] 1.05274e-05
alsin [NCBI] 1.05274e-05
HLCS [NCBI] 1.05274e-05
CALCR [NCBI] 1.05274e-05
NQO1 [NCBI] 1.05274e-05
NPAS2 [NCBI] 1.05274e-05
TPM1 [NCBI] 1.05274e-05
VCP [NCBI] 1.04475e-05
DRPLA [NCBI] 1.03679e-05
OPMD [NCBI] 1.03465e-05
SLC4A1 [NCBI] 1.03173e-05
NF1 [NCBI] 1.02571e-05
CLN2 [NCBI] 1.02301e-05
HRPT1 [NCBI] 1.02301e-05
PCLD [NCBI] 1.02301e-05
CBAVD [NCBI] 1.02301e-05
AIED [NCBI] 1.02301e-05
ARSA [NCBI] 1.01892e-05
CD14 [NCBI] 1.01316e-05
PLA2G7 [NCBI] 1.01316e-05
DCTN1 [NCBI] 1.01316e-05
NOTCH3 [NCBI] 1.01316e-05
PRX [NCBI] 1.01316e-05
CACNA1F [NCBI] 1.01316e-05
GAPDH [NCBI] 1.01041e-05
APOA1 [NCBI] 9.93919e-06
SOD1 [NCBI] 9.85219e-06
SIX5 [NCBI] 9.76425e-06
TMPO [NCBI] 9.76425e-06
POMT1 [NCBI] 9.76425e-06
NAGLU [NCBI] 9.76425e-06
DRD5 [NCBI] 9.76425e-06
PDC [NCBI] 9.76425e-06
KCNQ2 [NCBI] 9.76425e-06
BMPR2 [NCBI] 9.76425e-06
SPG3A [NCBI] 9.76425e-06
CTNS [NCBI] 9.76425e-06
GALE [NCBI] 9.76425e-06
SLC1A3 [NCBI] 9.76425e-06
FOXP2 [NCBI] 9.76425e-06
SDHB [NCBI] 9.76425e-06
oncogene dj1 [NCBI] 9.76425e-06
mucopolysaccharidosis type iiib [NCBI] 9.49697e-06
canavan disease [NCBI] 9.49697e-06
PLOSL [NCBI] 9.49697e-06
AAA [NCBI] 9.49697e-06
MEN2B [NCBI] 9.49697e-06
FA [NCBI] 9.47157e-06
MTR [NCBI] 9.46219e-06
PANK2 [NCBI] 9.42172e-06
ZEB2 [NCBI] 9.42172e-06
NPHS1 [NCBI] 9.42172e-06
THBD [NCBI] 9.42172e-06
SLC26A2 [NCBI] 9.42172e-06
PCSK1 [NCBI] 9.42172e-06
ATXN3 [NCBI] 9.42172e-06
SELE [NCBI] 9.42172e-06
CYP2C9 [NCBI] 9.42172e-06
ATP1A2 [NCBI] 9.42172e-06
MTTS1 [NCBI] 9.42172e-06
factor v deficiency [NCBI] 9.34747e-06
TCOF [NCBI] 9.20794e-06
APP [NCBI] 9.18871e-06
DLG4 [NCBI] 9.10109e-06
MIF [NCBI] 9.10109e-06
DLL3 [NCBI] 9.10109e-06
RNASEL [NCBI] 9.10109e-06
SCNN1B [NCBI] 9.10109e-06
CYP11A1 [NCBI] 9.10109e-06
PAX1 [NCBI] 9.10109e-06
ASS [NCBI] 9.01354e-06
CMH [NCBI] 8.94834e-06
PLN [NCBI] 8.9055e-06
RP [NCBI] 8.88196e-06
cutis laxa, x-linked [NCBI] 8.8166e-06
CGL2 [NCBI] 8.8166e-06
hyperoxaluria, primary, type i [NCBI] 8.8166e-06
pfeiffer syndrome [NCBI] 8.8166e-06
UCMD [NCBI] 8.8166e-06
SURF1 [NCBI] 8.79994e-06
SPHK1 [NCBI] 8.79994e-06
C5 [NCBI] 8.79994e-06
IL6R [NCBI] 8.79994e-06
TPM3 [NCBI] 8.79994e-06
BHMT [NCBI] 8.79994e-06
SPG7 [NCBI] 8.79994e-06
HBZ [NCBI] 8.79994e-06
RNASE3 [NCBI] 8.59963e-06
SMAX1 [NCBI] 8.54125e-06
RETN [NCBI] 8.51621e-06
XRCC9 [NCBI] 8.51621e-06
KCNJ2 [NCBI] 8.51621e-06
PTPN22 [NCBI] 8.51621e-06
SLC6A8 [NCBI] 8.51621e-06
PRKCG [NCBI] 8.51621e-06
KRIT1 [NCBI] 8.51621e-06
HMOX1 [NCBI] 8.51621e-06
ECM1 [NCBI] 8.51621e-06
BTK [NCBI] 8.48871e-06
GBA [NCBI] 8.48871e-06
CNTF [NCBI] 8.46909e-06
COL2A1 [NCBI] 8.28907e-06
PHOX2B [NCBI] 8.24815e-06
SFTPB [NCBI] 8.24815e-06
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase [NCBI] 8.24815e-06
CYGB [NCBI] 8.24815e-06
DBT [NCBI] 8.24815e-06
phenylketonuria ii [NCBI] 8.24815e-06
ulcerative colitis, susceptibility to [NCBI] 8.18399e-06
CHAC [NCBI] 8.18399e-06
sialuria, finnish type [NCBI] 8.18399e-06
PPH1 [NCBI] 8.18399e-06
mucolipidosis iv [NCBI] 8.18399e-06
fraser syndrome [NCBI] 8.18399e-06
CNC1 [NCBI] 8.18399e-06
TNFSF6 [NCBI] 8.15573e-06
porphyria variegata [NCBI] 8.15205e-06
SVAS [NCBI] 8.15205e-06
gaucher disease, type i [NCBI] 8.15205e-06
XK [NCBI] 7.99428e-06
EPHB2 [NCBI] 7.99428e-06
GJB6 [NCBI] 7.99428e-06
CLN3 [NCBI] 7.99428e-06
CTSD [NCBI] 7.99428e-06
DCX [NCBI] 7.99428e-06
HLA-G [NCBI] 7.99428e-06
VDR [NCBI] 7.92312e-06
DBH [NCBI] 7.7533e-06
MPL [NCBI] 7.7533e-06
PLOD1 [NCBI] 7.7533e-06
CPM [NCBI] 7.7533e-06
FOXC2 [NCBI] 7.7533e-06
MYB [NCBI] 7.7533e-06
DKC1 [NCBI] 7.7533e-06
MLC [NCBI] 7.5948e-06
hodgkin lymphoma [NCBI] 7.5948e-06
MADA [NCBI] 7.5948e-06
DRD [NCBI] 7.5948e-06
USH2A [NCBI] 7.5948e-06
diastrophic dysplasia [NCBI] 7.5948e-06
TCOF1 [NCBI] 7.52409e-06
SDHD [NCBI] 7.52409e-06
APTX [NCBI] 7.52409e-06
CYP1B1 [NCBI] 7.52409e-06
WFS1 [NCBI] 7.52409e-06
NKX2-1 [NCBI] 7.52409e-06
GH1 [NCBI] 7.45564e-06
TGFBI [NCBI] 7.30567e-06
HNF1B [NCBI] 7.30567e-06
EMD [NCBI] 7.30567e-06
MSX1 [NCBI] 7.30567e-06
CRYAA [NCBI] 7.30567e-06
CYP11B1 [NCBI] 7.30567e-06
LHB [NCBI] 7.30567e-06
MIP [NCBI] 7.09718e-06
MYH9 [NCBI] 7.09718e-06
osteoporosis [NCBI] 7.04525e-06
MTND2 [NCBI] 6.89784e-06
IL2RG [NCBI] 6.89784e-06
LDHB [NCBI] 6.89784e-06
BMP15 [NCBI] 6.89784e-06
CDKN1C [NCBI] 6.89784e-06
SLN [NCBI] 6.89784e-06
PMS2 [NCBI] 6.89784e-06
SCN1A [NCBI] 6.89784e-06
MTM1 [NCBI] 6.89784e-06
CMM [NCBI] 6.83889e-06
SLC22A5 [NCBI] 6.70698e-06
GJA5 [NCBI] 6.70698e-06
CRYAB [NCBI] 6.70698e-06
LRP8 [NCBI] 6.70698e-06
TTR [NCBI] 6.63695e-06
PDB [NCBI] 6.53202e-06
charge syndrome [NCBI] 6.53202e-06
central core disease of muscle [NCBI] 6.53202e-06
GJA8 [NCBI] 6.524e-06
KL [NCBI] 6.524e-06
TNNT2 [NCBI] 6.524e-06
PROP1 [NCBI] 6.524e-06
PRSS1 [NCBI] 6.34835e-06
SLC25A4 [NCBI] 6.34835e-06
IGF2R [NCBI] 6.34835e-06
ARSB [NCBI] 6.34835e-06
TTN [NCBI] 6.17954e-06
GSTP1 [NCBI] 6.17954e-06
DISC1 [NCBI] 6.17954e-06
GP1BA [NCBI] 6.17954e-06
BMP4 [NCBI] 6.0533e-06
pheochromocytoma [NCBI] 6.05223e-06
diabetes insipidus, nephrogenic, x-linked [NCBI] 6.05223e-06
CSTB [NCBI] 6.01713e-06
NCOA3 [NCBI] 6.01713e-06
CYP11B2 [NCBI] 6.01713e-06
DPYD [NCBI] 6.01713e-06
IRS2 [NCBI] 6.01713e-06
TWIST1 [NCBI] 6.01713e-06
CAV3 [NCBI] 6.01713e-06
OFC1 [NCBI] 5.96471e-06
IGF1R [NCBI] 5.86073e-06
ALDH3A2 [NCBI] 5.86073e-06
ALPL [NCBI] 5.86073e-06
GCH1 [NCBI] 5.86073e-06
SMAD4 [NCBI] 5.86073e-06
SLC40A1 [NCBI] 5.86073e-06
KRT5 [NCBI] 5.70996e-06
SPINK1 [NCBI] 5.64992e-06
FHM1 [NCBI] 5.60328e-06
mucopolysaccharidosis type vii [NCBI] 5.60328e-06
CCND1 [NCBI] 5.58539e-06
PAFAH1B1 [NCBI] 5.56449e-06
PPOX [NCBI] 5.42403e-06
MTTK [NCBI] 5.42403e-06
CDK6 [NCBI] 5.42403e-06
ICAM1 [NCBI] 5.28829e-06
IL13 [NCBI] 5.28829e-06
IGKC [NCBI] 5.28829e-06
SPP1 [NCBI] 5.23023e-06
usher syndrome, type i [NCBI] 5.1829e-06
HSAS [NCBI] 5.1829e-06
BOR1 [NCBI] 5.1829e-06
MDM2 [NCBI] 5.15702e-06
AVPR2 [NCBI] 5.15702e-06
MYO7A [NCBI] 5.15702e-06
PTHR1 [NCBI] 5.15702e-06
CTCF [NCBI] 5.15702e-06
PAI1 [NCBI] 5.15702e-06
ESR2 [NCBI] 5.02998e-06
ALDH2 [NCBI] 5.02998e-06
ASPA [NCBI] 5.02998e-06
MTCO1 [NCBI] 5.02998e-06
LTA [NCBI] 5.02998e-06
ATP7A [NCBI] 5.02998e-06
INSR [NCBI] 4.97882e-06
FANCC [NCBI] 4.90696e-06
SHOX [NCBI] 4.90696e-06
wolman disease [NCBI] 4.90696e-06
ABO [NCBI] 4.90696e-06
OPTN [NCBI] 4.90696e-06
STGD1 [NCBI] 4.78904e-06
leiomyomatosis and renal cell cancer, hereditary [NCBI] 4.78904e-06
HNMT [NCBI] 4.78775e-06
NOD2 [NCBI] 4.78775e-06
NR0B1 [NCBI] 4.78775e-06
GAMT [NCBI] 4.78775e-06
TS [NCBI] 4.7326e-06
DES [NCBI] 4.67218e-06
CTLA4 [NCBI] 4.45123e-06
TFR2 [NCBI] 4.45123e-06
FOLH1 [NCBI] 4.45123e-06
NRCLP1 [NCBI] 4.41987e-06
HHC1 [NCBI] 4.41987e-06
BRAF [NCBI] 4.34555e-06
GLA [NCBI] 4.34555e-06
CYP17A1 [NCBI] 4.24287e-06
NS1 [NCBI] 4.16756e-06
tyrosinemia, type i [NCBI] 4.14307e-06
ATRX [NCBI] 4.04602e-06
MTATP6 [NCBI] 4.04602e-06
IFNG [NCBI] 3.95161e-06
HBG2 [NCBI] 3.85973e-06
ALAD [NCBI] 3.85973e-06
TLR5 [NCBI] 3.85973e-06
LEP [NCBI] 3.81142e-06
AR [NCBI] 3.79853e-06
IDDM [NCBI] 3.7834e-06
BLM [NCBI] 3.7702e-06
HPS [NCBI] 3.72297e-06
CASR [NCBI] 3.72268e-06
RIPK1 [NCBI] 3.51558e-06
MTND1 [NCBI] 3.51558e-06
SCN5A [NCBI] 3.51558e-06
costello syndrome [NCBI] 3.44484e-06
SPG3A [NCBI] 3.44484e-06
mitochondrial complex iv deficiency [NCBI] 3.44484e-06
GALT [NCBI] 3.43494e-06
FLNA [NCBI] 3.43494e-06
AGT [NCBI] 3.43494e-06
TF [NCBI] 3.41216e-06
PROCR [NCBI] 3.35631e-06
SLC18A2 [NCBI] 3.27961e-06
KIT [NCBI] 3.27961e-06
INSL3 [NCBI] 3.27961e-06
MYH7 [NCBI] 3.27961e-06
HFM [NCBI] 3.14106e-06
DFFB [NCBI] 3.13174e-06
SLC6A3 [NCBI] 3.06958e-06
SLC2A2 [NCBI] 3.06044e-06
CEL [NCBI] 3.06044e-06
KCNQ1 [NCBI] 2.92284e-06
MMP9 [NCBI] 2.92284e-06
mitochondrial complex i deficiency [NCBI] 2.89198e-06
drug metabolism, poor, cyp2d6-related [NCBI] 2.89198e-06
CADASIL [NCBI] 2.89198e-06
sandhoff disease [NCBI] 2.89198e-06
MTND4 [NCBI] 2.85642e-06
HRAS [NCBI] 2.85642e-06
HNF4A [NCBI] 2.85642e-06
HEMB [NCBI] 2.82229e-06
NF2 [NCBI] 2.79153e-06
ITGB3 [NCBI] 2.79153e-06
AS [NCBI] 2.76678e-06
polycystic kidneys [NCBI] 2.76678e-06
LRP1 [NCBI] 2.75506e-06
SPTA1 [NCBI] 2.72812e-06
SCZD [NCBI] 2.72196e-06
BTC [NCBI] 2.66613e-06
malaria, susceptibility to [NCBI] 2.64133e-06
OPA1 [NCBI] 2.64133e-06
GCPS [NCBI] 2.64133e-06
WFS1 [NCBI] 2.64133e-06
MBL2 [NCBI] 2.60821e-06
ELN [NCBI] 2.60553e-06
ADHD [NCBI] 2.4804e-06
ABCC1 [NCBI] 2.43212e-06
NR5A1 [NCBI] 2.43165e-06
ATS [NCBI] 2.40659e-06
nijmegen breakage syndrome [NCBI] 2.40659e-06
REG3A [NCBI] 2.3762e-06
SHH [NCBI] 2.33425e-06
AQP2 [NCBI] 2.32195e-06
H6PD [NCBI] 2.21692e-06
DRD4 [NCBI] 2.21692e-06
aHUS [NCBI] 2.18691e-06
mucolipidosis ii [NCBI] 2.18691e-06
FSHR [NCBI] 2.16606e-06
FGA [NCBI] 2.06755e-06
XIST [NCBI] 2.01983e-06
TPO [NCBI] 2.0161e-06
COMP [NCBI] 1.99884e-06
HBG1 [NCBI] 1.9731e-06
TSHR [NCBI] 1.88252e-06
SNCA [NCBI] 1.83862e-06
FFI [NCBI] 1.80683e-06
MTS [NCBI] 1.78958e-06
KCNH2 [NCBI] 1.72188e-06
STAT6 [NCBI] 1.7122e-06
MTHFR [NCBI] 1.7122e-06
CD [NCBI] 1.66035e-06
CDSP [NCBI] 1.61053e-06
VHL [NCBI] 1.59328e-06
MAG [NCBI] 1.56794e-06
TNFRSF1A [NCBI] 1.41042e-06
DBA [NCBI] 1.24229e-06
BCR [NCBI] 1.21465e-06
EDMD [NCBI] 1.14444e-06
IL4 [NCBI] 1.09519e-06
ALPS [NCBI] 1.05975e-06
MAS [NCBI] 1.04241e-06
TYR [NCBI] 1.03933e-06
NSF [NCBI] 1.03933e-06
IDE [NCBI] 1.03933e-06
DYT1 [NCBI] 1.01096e-06
SCS [NCBI] 1.01096e-06
BDNF [NCBI] 1.00699e-06
GUSB [NCBI] 9.59593e-07
CPB2 [NCBI] 9.34057e-07
SLC6A4 [NCBI] 9.2941e-07
FGFR3 [NCBI] 9.24923e-07
CD [NCBI] 7.39946e-07
AIS [NCBI] 6.91434e-07
PPARG [NCBI] 6.84623e-07
hypertrophic neuropathy of dejerine-sottas [NCBI] 6.69529e-07
BRRS [NCBI] 6.69529e-07
ESR1 [NCBI] 6.64597e-07
UCN [NCBI] 6.44982e-07
ATM [NCBI] 6.25769e-07
TLR4 [NCBI] 6.15384e-07
UCP2 [NCBI] 6.06954e-07
TNFSF10 [NCBI] 5.79286e-07
HNPP [NCBI] 5.74017e-07
obesity [NCBI] 5.74017e-07
GRA [NCBI] 5.74017e-07
sickle cell anemia [NCBI] 5.74017e-07
dystrophia myotonica 1 [NCBI] 5.68309e-07
HP [NCBI] 5.20899e-07
von willebrand disease [NCBI] 5.0204e-07
IP [NCBI] 4.90297e-07
ACE [NCBI] 4.87671e-07
maple syrup urine disease [NCBI] 4.87029e-07
CCM [NCBI] 4.87029e-07
HHF2 [NCBI] 4.87029e-07
AN2 [NCBI] 4.87029e-07
NR1I2 [NCBI] 4.82861e-07
FGFR1 [NCBI] 4.09916e-07
SCA7 [NCBI] 4.08224e-07
CLS [NCBI] 4.08224e-07
AFP [NCBI] 4.03989e-07
LPL [NCBI] 3.56478e-07
BCHE [NCBI] 3.55545e-07
AHO [NCBI] 3.45377e-07
bullous erythroderma ichthyosiformis congenita of brocq [NCBI] 3.37282e-07
AMH [NCBI] 3.3509e-07
BWS [NCBI] 3.26212e-07
HBA1 [NCBI] 3.19135e-07
TBP [NCBI] 3.05084e-07
RCC1 [NCBI] 2.73901e-07
ED1 [NCBI] 2.73901e-07
UCP1 [NCBI] 2.70658e-07
PON1 [NCBI] 2.491e-07
osteogenesis imperfecta, type i [NCBI] 2.46537e-07
breast cancer [NCBI] 2.46537e-07
CDK5 [NCBI] 2.442e-07
STAR [NCBI] 2.4011e-07
VWS [NCBI] 2.17795e-07
SCA2 [NCBI] 2.0279e-07
DGS [NCBI] 1.83159e-07
LCAT [NCBI] 1.71533e-07
NPC1 [NCBI] 1.68695e-07
alopecia, androgenetic [NCBI] 1.62968e-07
DMD [NCBI] 1.34114e-07
TERT [NCBI] 1.34075e-07
SDC2 [NCBI] 1.31248e-07
PSACH [NCBI] 1.27181e-07
BPES [NCBI] 1.26347e-07
KSS [NCBI] 9.70033e-08
PMD [NCBI] 9.05491e-08
EIG [NCBI] 9.05491e-08
MKS1 [NCBI] 9.05082e-08
LQT1 [NCBI] 9.05082e-08
HOS [NCBI] 6.09518e-08
hypogonadotropic hypogonadism [NCBI] 4.52333e-08
glycogen storage disease ii [NCBI] 4.52333e-08
menkes disease [NCBI] 4.52333e-08
ABCG2 [NCBI] 4.50138e-08
DNMT1 [NCBI] 3.74743e-08
POMC [NCBI] 2.89122e-08
CES [NCBI] 1.98302e-08
CDK4 [NCBI] 1.68019e-08
FAAH [NCBI] 7.48248e-09
LPI [NCBI] 4.14332e-09
ND [NCBI] 4.14332e-09
velocardiofacial syndrome [NCBI] 4.14332e-09
DMD [NCBI] 1.99764e-09
HGPS [NCBI] 1.37737e-09
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 1.04237e-09
EPOR [NCBI] 4.05844e-11



Database Center for Life Science